Furthermore, combining CPIs with application of intratumoral TLR7/8 activation results in myeloid cell activation and antigen-presenting cell (APC) maturation in the tumor microenvironment to augment the activity and specificity of adaptive immune responses [21]. This evidence concerns the gene TLR7 and neoplasm.